Ticker: EIGR
Eiger BioPharmaceuticals Inc
$9.96
(+0.81%)
Since 2019
$
Real time stock price updated as of October 22, 2020, 4:55 PM
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Invest in Eiger BioPharmaceuticals Inc on Stash
Eiger BioPharmaceuticals Inc. is a late-stage biopharmaceutical company.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Historical stock performance
Last 1 week | 18.41% |
Last 1 month | 2.21% |
Last 12 months | -4.33% |
Last 3 years | -7.41% |
Last 5 years | -10.05% |
Last 10 years | -- |
Last 15 years | -- |
Since inception | -33.98% |
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Eiger BioPharmaceuticals Inc stock News
This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.
24/7 Wall Street
24 days ago
Eiger BioPharmaceuticals COVID-19 Study Fails to Live Up to Expectations
Eiger BioPharmaceuticals Inc. (NASDAQ: EIGR) has announced disappointing results from an investigator-sponsored study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.
CNBC
about 2 hours ago
Intel drops on weak results for its data center group
The pandemic fueled growth in Intel's PC business, but data center spending fell off in the quarter.
24/7 Wall Street
about 2 hours ago
Does Intel Deserve More Credit For Q3 Earnings?
Intel Corp. (NASDAQ: INTC) reported third-quarter financial results after markets closed Thursday.
CNBC
about 2 hours ago
FDA approves Gilead's remdesivir as coronavirus treatment
The Food and Drug Administration on Thursday approved Gilead Sciences' antiviral drug remdesivir as a treatment for the coronavirus.
Why invest on Stash?
Invest affordably.
You can buy pieces of stocks and funds with any dollar amount—and our subscription plans start at just $1 per month.
Enjoy unlimited trading.
Unlike other investing apps, Stash also doesn't charge any add-on trading commissions or electronic statement fees.1
Learn how to invest.
We'll help teach you how to invest confidently through tips, articles, and ongoing personalized guidance.
Stay diversified.
We can help guide you through building a custom balanced portfolio with our
1Stash may incur ancillary fees charged by Stash and/or its custodian that are not included in the monthly Wrap-Fee.
How to buy Eiger BioPharmaceuticals Inc stock on Stash
1. Enter the amount you'd like to invest in Eiger BioPharmaceuticals Inc stock, then proceed to checkout.
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Read more
2. Choose a Stash plan and set up your investment account in just a few minutes.
Stash offers three subscription plans: Stash Beginner, Stash Growth, and Stash+. Our Beginner plan starts at just $1 per month.
Read more
3. Once you’ve finished your account, your Eiger BioPharmaceuticals Inc shares will be added to your new portfolio.
Once your market order of Eiger BioPharmaceuticals Inc stock is complete, you'll officially be a shareholder of Eiger BioPharmaceuticals Inc!
Read more
Invest in Eiger BioPharmaceuticals Inc on Stash
Eiger BioPharmaceuticals Inc. is a late-stage biopharmaceutical company.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Stash resources for confident investing
How to Start Investing
Getting started in the world can be intimidating. Take a look at some of these basics we put together so you can learn how to start investing.
Investing in Fractional Shares on Stash
Good news: Learn how fractional shares can make an investment a lot more affordable.
Here’s How to Research Stocks
Consider P/E ratio, profit and loss, and news when buying stocks.
Subscribe to The Wallet!
Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!
More Health Care stocks
INCY
Incyte Corp
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late-stage development, and commercialized products, such as JAKAFI (ruxolitinib) and ICLUSIG (ponatinib).
CHE
Chemed Corp
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter).
VMD
Viemed Healthcare Inc
Viemed Healthcare Inc is Canada-based company engaged in Healthcare sector. The company is focused on education, nurture, and inspiration of its patients, through a effective home treatment model, that integrates easily into the processes of its referral partners.
ALKS
Alkermes PLC
Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas.
INO
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases.
JNJ
Johnson & Johnson
The historic health-care company operates more than 260 companies in over 60 countries.
147k+ reviews on App Store and Google Play™ Store
Over 3 million Americans use Stash to invest, save, and spend.
This is not an endorsement or a statement of satisfaction.
